Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
about
PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsCould Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?Repurposing the antipsychotic trifluoperazine as an antimetastasis agent.Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.Peptide receptor targeting in cancer: the somatostatin paradigm.BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.Prolactin regulation of the prostate gland: a female player in a male game.Radiolabeled heterobivalent peptidic ligands: an approach with high future potential for in vivo imaging and therapy of malignant diseases.A novel report of apoptosis in human lung carcinoma cells using selective agonist of D2-like dopamine receptors: a new approach for the treatment of human non-small cell lung cancer.Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins.Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells
P2860
Q26862544-164F301F-4CC5-4C55-9EB4-6E63BECC0422Q35148094-5707513A-C25B-46E5-B780-E56317FDD82CQ35536672-510A9028-17C8-4C72-8E0B-AB7EAA1424ACQ35650633-491EFC0D-167C-47F4-A032-47DCBFED0F24Q36638046-CDF95DA4-DD31-4D50-A4AB-349C66816A30Q37633385-85639D4C-05F9-438B-B130-7F03CADA7A66Q37942413-CF684760-1026-4C60-82BE-12352ECA6A34Q38096994-5980FE5D-F64C-4598-8D14-6A9C47B46328Q39141079-25A54542-9549-4190-8643-DB46967A1444Q54353594-C16E9CFD-FC37-4115-B0F4-AA52CCB05B27Q57679679-DF8CA7A4-D30D-48AD-A404-06FCAFD3CBA0
P2860
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
@en
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
@nl
type
label
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
@en
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
@nl
prefLabel
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
@en
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
@nl
P2093
P50
P356
P1476
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines
@en
P2093
P304
P356
10.1677/JOE-10-0342
P407
P577
2010-09-27T00:00:00Z